Abbott Receives FDA Approval for Simcor (Niaspan / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
ABBOTT PARK, Ill., February 15, 2008 /PRNewswire-FirstCall/ -- Today, Abbott received U.S. Food and Drug Administration (FDA) approval for Simcor, the first fixed-dose combination of two widely prescribed cholesterol therapies, Niaspan... (Source: Drugs.com - New Drug Approvals)div id=medwormpbiMedWorm Message:/i/b Please have a look at this new site driven by MedWorm: a href=http://www.thebreastcancerdaily.com/ target=_blankThe Breast Cancer Daily/a/p/div

SIMCOR (Simvastatin And Niacin) Tablet, Film Coated, Extended Release [Abbott Laboratories]
Updated Date: Feb 14, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))